Omid Seidizadeh: Advancing Genomic Insights into Bleeding Disorders at ISTH 2026
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared a post on LinkedIn:
“It was a pleasure to attend the International Society on Thrombosis and Haemostasis (ISTH) 2026 and meet many colleagues, collaborators, and scientists working across the fields of hemostasis and thrombosis.
During the meeting, I presented our data on whole-exome sequencing in patients with low von Willebrand factor and also had the opportunity to discuss our work on estimating the global and population prevalence of coagulation disorders using large-scale genomic databases at the ISTH SSC Omics session.
It was a great week of science, discussions, and new ideas, and I look forward to seeing how these conversations develop in the coming years.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 17:54Tareq Abadl: Extravascular Hemolysis The High-Yield Guide
-
Sep 3, 2026, 17:48Isabel Sá: Starting a New Chapter as a Clinical Scientist in Molecular Genetics and Haematology
-
Sep 3, 2026, 17:40Chiwoo Oh: AS01B Adjuvant and Long-Term Immune Reprogramming After Shingrix Vaccination
-
Sep 3, 2026, 17:35Key Developments in Transfusion Medicine and Biotherapies in 2025 – AABB
-
Sep 3, 2026, 17:24N. Mariana S. Vasquez: JAK2 Mutations The High-Yield Map of Myeloproliferative Neoplasms
-
Sep 3, 2026, 17:08Khusi Dhara: Why Women Need to Pay Attention to Iron
-
Sep 3, 2026, 16:54Ralf Ludwig։ Testing Human-Targeted Therapies in a Human Immune System
-
Sep 3, 2026, 16:35Mohsen Salimi: Non-Contrast Chest CT as a Biomarker for Mild-to-Moderate Anemia
-
Sep 3, 2026, 16:10Tanzeel Alamin Almahdi Gorashi: NLR as an Accessible Biomarker for Monitoring Pediatric Sickle Cell Anemia